Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight over a period of 6 to 12 months without a clear etiology, poses a significant diagnostic challenge for clinicians. This article aims to provide a comprehensive guide to help clinicians methodically approach this issue and optimize patient care.
Firstly, a detailed patient history is paramount. This should include dietary habits, physical activity, social circumstances, and medication use. A comprehensive physical examination can reveal signs of malnutrition, malignancy, endocrine disorders, or gastrointestinal diseases. These findings can guide further investigations.
Initial laboratory investigations should include a complete blood count, liver and kidney function tests, electrolyte levels, thyroid function tests, and tests for diabetes. Imaging studies, such as CT scans or ultrasounds, can be helpful in identifying occult malignancies or other systemic diseases. If these tests are inconclusive, more specific investigations may be warranted based on the patient's history and physical examination.
It's important to consider age-related factors. In older adults, UWL may be a sign of malignancy, while in younger patients, it may suggest psychiatric conditions like depression or eating disorders. Additionally, UWL could be a symptom of a chronic infection such as HIV or tuberculosis, especially in high-risk populations.
If the cause of UWL remains elusive after thorough evaluation, referral to a specialist, such as a gastroenterologist, endocrinologist, or psychiatrist, may be necessary. These specialists can offer further diagnostic tests and management options.
Unexplained weight loss is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations can often identify the underlying cause. In cases where the cause remains unclear, referral to a specialist is recommended. By adopting this comprehensive approach, clinicians can ensure optimal patient care and management.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation